drugset / Trial / NCT00108134

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Superficial Basal Cell Carcinoma

NCT00108134

Phase 2 Completed 60 enrolled Peplin
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether topical application of PEP005 is safe for the treatment of superficial basal cell carcinoma.

Timeline

Start
2005-03
Primary completion
2006-03
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ingenol mebutate Small molecule 0.0025 % Topical
Subject ingenol mebutate Small molecule 0.01 % Topical
Subject ingenol mebutate Small molecule 0.05 % Topical